Tavolixizumab (Anti-TNFRSF4 / OX40 / CD134)Tavolixizumab (Anti-TNFRSF4 / OX40 / CD134)
Move your mouse over image or click to enlarge

Tavolixizumab (Anti-TNFRSF4 / OX40 / CD134)

Tavolixizumab (Anti-TNFRSF4 / OX40 / CD134) is a human monoclonal antibody targeting TNFRSF4 (TNF receptor superfamily member 4) and OX40. It can be used in cancer immunology research. MW :146.36 KD.
Cat# Size Price Qty Buy
A2683-1mg*25 1mg*25
£2,432.00
A2683-1mg*5 1mg*5
£794.00
A2683-1mg 1mg
£303.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2683

Related Documents